[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343356-105":59,"doc-detail-343356-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exploring-the-prognostic-role-of-d-dimer-levels-in-pancreatic-cancer-a-comprehensive-review-of-clinicopathological-associations","Exploring the Prognostic Role of D-dimer Levels in Pancreatic Cancer - A Comprehensive Review of Clinicopathological Associations","","Pancreatic cancer is associated with a poor prognosis and high mortality, largely driven by late-stage detection and aggressive progression. Identifying reliable prognostic biomarkers is essential to improve outcomes and support treatment planning. This comprehensive review synthesizes evidence on D-dimer, a fibrin degradation product, evaluating its prognostic value in pancreatic cancer and its links to clinicopathological characteristics. Elevated D-dimer levels are associated with worse survival and greater disease progression. The review also discusses measurement challenges, emphasizes the need for standardized protocols, and outlines future research to validate clinical utility for risk stratification and personalized care.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-the-prognostic-role-of-d-dimer-levels-in-pancreatic-cancer-a-comprehensive-review-of-clinicopathological-associations/343356/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-the-prognostic-role-of-d-dimer-levels-in-pancreatic-cancer-a-comprehensive-review-of-clinicopathological-associations/343356.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is a prognostic biomarker important in pancreatic cancer?","Question",{"text":112,"@type":113},"Pancreatic cancer has a dismal prognosis due to late-stage diagnosis and aggressive progression. Reliable biomarkers help guide treatment strategies and improve patient outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the review report about D-dimer levels in pancreatic cancer?",{"text":117,"@type":113},"Higher D-dimer levels in pancreatic cancer patients are linked to poorer clinical outcomes, including reduced overall survival and increased disease progression.",{"name":119,"@type":110,"acceptedAnswer":120},"What issues does the review highlight regarding D-dimer testing?",{"text":121,"@type":113},"The review addresses methodological challenges in D-dimer measurement and stresses the need for standardized protocols to improve reliability and applicability.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343356,1791212857,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Received 08/25/2024  \nReview began 08/30/2024  \nReview ended 08/31/2024  \nPublished 09/04/2024  \n© Copyright 2024  \nDixit et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. , which permits unrestricted use , distribution , and reproduction in any medium , provided the original author and source are credited.  \nDOI: 10.7759/cureus.68627  \nOpen Access Review Article  \nPublished via DMIHER Datta Meghe Medical College  \nExploring the Prognostic Role of D-dimer Levels in Pancreatic Cancer: A Comprehensive Review of Clinicopathological Associations  \nSparsh Dixit 1, Chandrashekhar Mahakalkar 1, Shivani Kshirsagar 1, Akansha Hatewar 1  \n1. General Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND  \nCorresponding author: Sparsh Dixit, [drsparshdixit@gmail.com](drsparshdixit@gmail.com)  \nAbstract  \nPancreatic cancer is known for its dismal prognosis and high mortality rate, primarily due to late-stage diagnosis and aggressive disease progression. Finding reliable prognostic biomarkers is crucial in improving patient outcomes and guiding treatment strategies. D-dimer, a fibrin degradation product, has emerged as a potential biomarker of interest in various cancers due to its association with coagulation abnormalities. This comprehensive review investigates the prognostic role of D-dimer levels in pancreatic cancer by synthesizing current research and exploring its clinicopathological associations. Elevated D-dimer levels in pancreatic cancer patients have been linked to poorer clinical outcomes, including reduced overall survival and increased disease progression. The review examines how D-dimer levels correlate with tumor characteristics such as stage, grade, and metastatic spread, highlighting its potential utility as a prognostic marker. Additionally, the review addresses the methodological challenges in D-dimer measurement and the need for standardized protocols to enhance the reliability and applicability of results. Future research directions are identified, focusing on validating D-dimer 's clinical utility and integrating it into routine practice for risk stratification and personalized treatment planning. By providing a comprehensive overview of D-dimer 's prognostic value, this review aims to contribute to developing more effective management strategies for pancreatic cancer, ultimately improving patient care and outcomes.  \nCategories: Internal Medicine, Medical Education, Medical Simulation  \nKeywords: survival outcomes, tumor progression, coagulation, prognostic biomarker, d-dimer, pancreatic cancer  \nIntroduction And Background  \nPancreatic cancer is a formidable challenge in oncology, marked by its high incidence and dismal prognosis [1] . As of 2024, it stands as the fourth leading cause of cancer-related deaths worldwide. Despite advancements in medical research, the five-year survival rate for pancreatic cancer patients remains critically low, hovering around 11%[2] . This poor outlook is largely due to the cancer 's tendency to beasymptomatic in its early stages, resulting in diagnoses at advanced stages when treatment options are limited. The disease 's aggressive nature and propensity for early metastasis further contribute to its poor prognosis [3] . The pathology of pancreatic cancer primarily involves pancreatic ductal adenocarcinoma (PDAC), a malignant tumor originating from the ductal cells of the pancreas. This cancer is driven by a complex array of genetic mutations, including those in the KRAS, TP53, CDKN2A, and SMAD4 genes. These mutations lead to unchecked tumor growth, early dissemination, and resistance to conventional therapies. Compounding these issues is the presence of a desmoplastic stroma, which not only supports tumor growth but also impedes effective drug delivery and immune system infiltration, further complicating treatment efforts [4] .  \nIn the broader context of ","cbCaivrVheqRpWht","https://ap.wps.com/l/cbCaivrVheqRpWht","pdf",532389,"English","# Abstract\n# Introduction And Background\n## Biomarkers in cancer care\n## D-dimer and coagulation disorders\n# How to cite this article\n# Review\n## D-dimer: a biomarker overview\n## Definition and Biochemical Properties","[{\"question\":\"Why is a prognostic biomarker important in pancreatic cancer?\",\"answer\":\"Pancreatic cancer has a dismal prognosis due to late-stage diagnosis and aggressive progression. Reliable biomarkers help guide treatment strategies and improve patient outcomes.\"},{\"question\":\"What does the review report about D-dimer levels in pancreatic cancer?\",\"answer\":\"Higher D-dimer levels in pancreatic cancer patients are linked to poorer clinical outcomes, including reduced overall survival and increased disease progression.\"},{\"question\":\"What issues does the review highlight regarding D-dimer testing?\",\"answer\":\"The review addresses methodological challenges in D-dimer measurement and stresses the need for standardized protocols to improve reliability and applicability.\"}]","Exploring the Prognostic Role of D-dimer Levels in Pancreatic Cancer - A Comprehensive Review of Clinicopathological Associations | PDF",1790050860,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3454d8ba4aa4aa1333af5487492448af.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ffbed86762c19cff6b4b140571f475c.webp",982,1389,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9791ea49aad38f7c6c6b7e8954f8462d.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98cd9061cd3aca3d89baa4a9fdb6aee8.webp",980,1386]